Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2025-12-25 @ 6:59 PM
NCT ID: NCT00388804
Description: None
Frequency Threshold: 5
Time Frame: 4 years and 9 months
Study: NCT00388804
Study Brief: External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
RT Group 1 Radiation Therapy (RT) over 8 1/2 weeks: 42 treatments, 5 days per week with 2 days rest in between. None None 0 17 4 17 View
RT Group 2 + Hormone Therapy Radiation Therapy over 8 1/2 weeks; + Hormone Therapy (Bicalutamide 50 mg orally/day or Flutamide 250 mg orally 3 times daily on first 21-30 Days) + Leuprolide (22.5 mg Intramuscularly (IM)/every 3 months or 7.5 mg IM monthly) or Goserelin (10.8 mg subcutaneously every 3 months or 3.6 mg subcutaneously monthly) None None 0 21 1 21 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Urinary frequency SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE (3.0) View
Urinary incontinence SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE (3.0) View
Dysuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders CTCAE (3.0) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Alanine transaminase (ALT) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
Aspartate transaminase (AST) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View